Case Details

Citation(s)
2008 SLG 2530 2008 SLD 2530 (2008) 305 ITR 394 (2008) 174 TAXMAN 124
Authority for Advance Rulings, New Delhi

JUSTICE P.V. REDDI, CHAIRMAN AND A. SINHA AND RAO RANVIJAY SINGH, MEMBER

Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in /home/digixyei/sldsystempk.com/view/master-layout/view_case.php on line 395


Deprecated: preg_match(): Passing null to parameter #2 ($subject) of type string is deprecated in /home/digixyei/sldsystempk.com/view/master-layout/view_case.php on line 411

Deprecated: htmlspecialchars(): Passing null to parameter #1 ($string) of type string is deprecated in /home/digixyei/sldsystempk.com/view/master-layout/view_case.php on line 435

Law:

Section:

2008] 305 ITR 394 [2008] 174 Taxman 124 (AAR) AUTHORITY FOR ADVANCE RULINGS (INCOME-TAX), NEW DELHI Anapharm Inc., In re* JUSTICE P.V. REDDI, CHAIRMAN AND A. SINHA AND RAO RANVIJAY SINGH, MEMBER A.A.R. NO. 746 OF 2007 SEPTEMBER 11, 2008 Section 9 of the Income-tax Act, 1961, read with articles 7and 12 of the Double Taxation Avoidance Agreement between India and Canada - Income - Deemed to accrue or arise in India - Whether for considering a payment of consideration as 'fees for technical/included services' in terms of article 12(4)(b), mere provision of technical services is not enough; it additionally requires that service provider should also make its technical knowledge, experience, skill, know-how, etc., known to recipient of service so as to equip it to independently perform technical functions itself in future without help of service provider - Held, yes - Applicant is a company incorporated in Canada - It provides clinical and bioanalytical services to assist pharmaceutical companies around world in development of new drugs or generic copies of drugs already being marketed - It has entered into agreements with two Indian pharmaceutical companies for rendering said services - In terms of agreements, applicant provides to recipients only final results and conclusions of data of bioequivalence tests and not clinical procedure, analytical methods, etc., which are proprietary items of applicant - Clients pay fees to applicant in lieu of above services - Whether fees received by applicant for services provided to Indian companies can be considered to be 'fees for included services' within meaning of article 12(4) - Held, no - Whether fee paid by Indian companies to applicant in respect of bioequivalence tests conducted by it is in nature of 'business profits' under article 7 of DTAA and same is not taxable in India, as applicant does not have a permanent establishment in India - Held, yes FACTS The applicant is a company incorporated in Canada. It is a contract research organization which provides clinical and bioanalytical services to assist pharmaceutical companies around the world in the development of new drugs or generic copies of drugs already being…
🔒
Continue readingLogin or create an account to access the complete content.Login / Register

Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /home/digixyei/sldsystempk.com/view/master-layout/view_case.php on line 492